Sernova Biotherapeutics SEOVF

$0.09 +0.01 (6.29%)

Valuation

Market cap
34,479,000
Revenue TTM
$0
Net income TTM
$-11,240,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
-0.21

Trading

Volume
3,000
Avg volume
96,068
Day's range
$0.09 – $0.09
Shares out
377,642,000
Stochastic %K
100%
Beta
0.89
Analysts
Strong Buy
Price target
$0.57

Price

Company profile

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was...

Show more

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
917-751-5713
Website
https://www.sernova.com
Address
RPO Central Parkway, PO Box 29592, Mississauga, Canada

Latest news

No headlines yet.

Stocktwits

newsfile_corp Sep 11, 9:40 PM
https://nfne.ws/314074 $SEOVF $SVA.TSX #HealthCare #Agreement #OTC #OTCMarkets #OTCStocks #TSX #Investing
0 replies
BiotechButterflies Sep 11, 2:07 PM
$SEOVF ... a cool approach that deserves more attention that it's getting, now I'm also betting on the approaches by $SANA and $IPSC and assume that there will be plenty for for all three.. or anybody else that can bring solutions....
1 replies
3D_STOCK_TRADING Sep 9, 12:28 AM
$SEOVF Here we go people, check out the news. Train is leaving town.
1 replies
StreetwiseReports Jun 22, 4:44 PM
Sernova Biotherapeutics Advances Toward Diabetes Solutions with FDA Orphan Drug Designation and Strengthened Capital Base https://ow.ly/VGv850ZfljP Sernova Biotherapeutics leverages its Cell Pouch technology and recent FDA orphan drug designation to address type 1 and type 3c diabetes amid a growing global market, supported by improved financial stability for retail investors. $SVA.V $SEOVF
0 replies
StreetwiseReports Jun 19, 6:59 PM
Biotech Secures Major FDA Orphan Drug Designation for Diabetes Treatment https://ow.ly/bTzB50ZeJn4 Sernova Biotherapeutics Inc. ( $SVA.V $SEOVF ) announces it has been granted orphan drug designation for autologous islet transplantation (AIT) for preventing diabetes following a total pancreatectomy.
0 replies
3D_STOCK_TRADING Jun 17, 3:45 PM
$ELDN $SEOVF great news for Sernova. Eledon's best buddy!!!
0 replies
All4Retiring Jun 17, 1:49 PM
$SEOVF Nice!
0 replies
Anshoo Jun 17, 11:19 AM
$SEOVF Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy https://www.globenewswire.com/news-release/2026/06/17/3313292/0/en/Sernova-Biotherapeutics-Receives-FDA-Orphan-Drug-Designation-for-Autologous-Islet-Transplantation-for-Prevention-of-Diabetes-Due-to-Total-Pancreatectomy.html
0 replies